The European mergers and acquisitions (M&A) advisory landscape for Healthcare Technology (HealthTech) and Medical Technology (MedTech) is undergoing a structural realignment. For nearly three decades, corporate finance advisory within the healthcare vertical was dominated by career financiers whose professional core competencies centred on financial engineering, debt syndication, balance sheet restructuring and equity capital markets access. While these traditional investment